Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study. - Narita Y; Kawakami H; Nakanishi K; Makiyama A; Sugimoto N; Konishi H; Morita S; Minashi K; Imano M; Inamoto R; Nishina T; Kawakami T; et al. (Japanese journal of clinical oncology, 2026)